Chemotherapy may compromise previously adequate vaccine-induced immunity

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1251, 2000-01, pp. : 18-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Docetaxel added to standard chemotherapy does not compromise QOL

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 515, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Oxcarbazepine may prevent oxaliplatin-induced neuropathy in patients undergoing chemotherapy for advanced colon cancer

Inpharma, Vol. 1, Iss. 1574, 2007-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Pneumococcal vaccine may prevent atherogenesis

Inpharma, Vol. 1, Iss. 1395, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Smallpox: a new vaccine, and long-term immunity

Inpharma, Vol. 1, Iss. 1407, 2003-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Smallpox vaccinations: immunity may be long-lasting

Inpharma, Vol. 1, Iss. 1318, 2001-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite